What does AMRX stand for?
Mar 30, 2022 · Amneal Pharmaceuticals' stock was trading at $3.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, AMRX stock has increased by 35.7% and is now trading at $4.41. View which stocks have been most impacted by COVID-19.
Where can I buy AMRX shares?
View the latest Amneal Pharmaceuticals Inc. (AMRX) stock price, news, historical charts, analyst ratings and financial information from WSJ.
When will AMRX earnings call for 2019?
AMRX • NYSE. Amneal Pharmaceuticals Inc. Follow. $4.19. After Hours: $4.19. (0.00%) 0.00. Closed: Mar 18, 4:30:17 PM GMT-4 · USD · NYSE · Disclaimer. No data.
Is Amneal Pharmaceuticals (AMRX) a suitable pick for value investors?
5 rows · Compare AMRX Stock to Peers. Symbol. Last Price. Market Cap. % Δ 1 Yr. % Δ 5 Yr. AMRX. ...
Is AMRX stock a good buy?
Broad Value Outlook. In aggregate, Amneal Pharmaceuticals currently has a Value Style Score of A, putting it into the top 20% of all stocks we cover from this look. This makes AMRX a solid choice for value investors.Nov 16, 2020
Will amneal stock go up?
Stock Price Forecast The 5 analysts offering 12-month price forecasts for Amneal Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 6.00. The median estimate represents a +69.70% increase from the last price of 4.13.
Why is amneal stock down?
The business specifically cited fewer available customers and a greater-than-expected challenge from competitors as the core reasons for the lingering weakness in the generic-drug markets.Jul 10, 2019
Is amneal a good company?
Is Amneal Pharmaceuticals a good company to work for? Amneal Pharmaceuticals has an overall rating of 3.6 out of 5, based on over 317 reviews left anonymously by employees.Apr 13, 2022
Who bought Amneal?
Bisaro, who had a record of building generics companies through M&A, was running Impax Labs when it bought Amneal in 2017 for $6.4 billion.
When did Amneal go public?
May 7, 2018Shares of newly public AMRX began trading on the NYSE on May 7, 2018. Concurrent with the Impax merger, Amneal acquired Gemini Laboratories for $117 million, including Unithroid, Gemini's lead product for treating hypothyroidism.
What drugs does Amneal make?
Specialty ProductsRytary (carbidopa and levodopa) Extended Release Capsules.Unithroid (Levothyroxine)Emverm (mebendazole)Zomig (zolmitriptan) Nasal Spray.
Is Amneal Pharmaceuticals a buy right now?
2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Amneal Pharmaceuticals in the last year. There are currently 2 bu...
How has Amneal Pharmaceuticals' stock price been impacted by Coronavirus (COVID-19)?
Amneal Pharmaceuticals' stock was trading at $3.25 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World H...
Are investors shorting Amneal Pharmaceuticals?
Amneal Pharmaceuticals saw a increase in short interest in February. As of February 15th, there was short interest totaling 2,900,000 shares, an in...
When is Amneal Pharmaceuticals' next earnings date?
Amneal Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Friday, May 6th 2022. View our earnings forecast for Am...
How were Amneal Pharmaceuticals' earnings last quarter?
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) released its quarterly earnings data on Wednesday, March, 2nd. The company reported $0.18 earnings per sha...
What guidance has Amneal Pharmaceuticals issued on next quarter's earnings?
Amneal Pharmaceuticals issued an update on its FY 2022 earnings guidance on Wednesday, March, 16th. The company provided earnings per share guidanc...
What price target have analysts set for AMRX?
2 brokers have issued 1 year target prices for Amneal Pharmaceuticals' stock. Their forecasts range from $8.00 to $9.00. On average, they anticipat...
Who are Amneal Pharmaceuticals' key executives?
Amneal Pharmaceuticals' management team includes the following people: Chintu Patel , Co-Chief Executive Officer & Director Chirag K. Patel , Pr...
What is Chirag and Chintu Patel's approval rating as Amneal Pharmaceuticals' CEO?
23 employees have rated Amneal Pharmaceuticals CEO Chirag and Chintu Patel on Glassdoor.com . Chirag and Chintu Patel has an approval rating of 91...
How much does Amneal Pharmaceuticals make?
When is the earnings call for Amneal Pharmaceuticals?
Amneal Pharmaceuticals has a market capitalization of $1.45 billion and generates $1.99 billion in revenue each year. The company earns $91.06 million in net income (profit) each year or $0.52 on an earnings per share basis.
How long are futures trading delayed?
How can I listen to Amneal Pharmaceuticals' earnings call? Amneal Pharmaceuticals will be holding an earnings conference call on Monday, August 9th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "10158095".
How to calculate restricted stock?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
How to calculate P/E?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
